palmOne has announced that Invivodata, an industry leader in electronic Patient Reported Outcome (ePRO) solutions for clinical research, has plans to deploy between 5,000 and 7,000 Tungsten E2 handhelds for use worldwide in clinical trials during the next 90 days. As the demand for Invivodata's unique electronic diary system continues to grow, the number of deployed devices could easily reach four times that amount by the end of 2005.
posted by Kent 7:42 AM |
|
![[RSS 0.92 feed]](http://medicalpda.net/img/xml.gif)
